XLF News 22.67 06/27/2014 05:44:42 Financial Select Sector SPDR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Financial Select Sector SPDR (XLF) 22.67 $XLF

'Fast Money' Recap: Can GM Shares Drive Through $38?
at The Street - Thu Jun 26, 4:00AM CDT
The trading panel discussed whether General Motors and Google are worth buying.

Powerhouse ETFs: Transports and Technology Are the Best Performers
at The Street - Thu Jun 12, 10:58AM CDT
I continue to track 11 Exchange Traded Funds as a conservative way to invest in specific sectors of the stock market in an environment where stock-picking remains difficult.

Wall Street Bulls Salvage a Win
at The Street - Fri May 16, 4:19PM CDT
After trading most of Friday in the red, the indexes were able to close higher.

What is Driving Bank ETFs Lower? - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu May 15, 9:01AM CDT
Financial ETFs in the banking world have been hit hard lately, what is behind this slump?

Powerhouse ETFs: Energy, Consumer Staples and Utilities Outperform
at The Street - Mon May 12, 12:03PM CDT
There are 11 Exchange Traded Funds that provide a conservative way to invest in specific sectors without the risk of stock picking.

Insurance ETFs Crushing Financials on Q1 Earnings - ETF News And Commentary
Sweta Killa - ZACKS - Fri May 09, 1:00PM CDT
Insurance ETFs are leading the financial ETF space in the trailing one-month period on decent earnings.

Banking Sector Earnings Put These Financial ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 9:00AM CDT
Thanks to some big banks reporting as of late, these financial ETFs look to be in focus.

Utilities, Health Care Leading ETF Sectors
at The Street - Wed Apr 02, 9:15AM CDT
Here are some investments to get exposure to broad sectors in the economy.

March ETF Report: U.S. Equities Thrive, Emerging Markets Suffer - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 9:00AM CDT
These ETFs saw the biggest inflows and outflows for March 2014.

3 Dirt Cheap Top Ranked ETFs to Buy Now - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 12:00PM CDT
These ultra cheap ETFs could be solid investments for those looking for long term plays.

3 Financial ETFs to Play the Bank Stress Tests - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 9:00AM CDT
These financial ETFs look to be in focus following the recent bank stress tests.

First Week Of XLF July 19th Options Trading
at The Street - Wed Mar 26, 11:19AM CDT
Investors in Financial Select Sector SPDR Fund saw new options begin trading this week, for the July 19th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 115 days until...

Roundtable Top Picks for the Week of Mar. 24th - Video Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 3:52PM CDT
Ideas for Auto Parts, Financials and Pharmaceuticals. Opportunities covered include Motorcar Parts of America, Inc. (MPAA), Financial Select Sector SPDR Fund (XLF) and Horizon Pharmaceutical (HZNP).

Play Rising Rates with These ETFs - ETF News And Commentary
Sweta Killa - ZACKS - Fri Mar 21, 11:00AM CDT
Financials ETFs would be the main beneficiary of a rising interest rates environment.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 114

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
AvidXchange Acquisition Faces Fairness Investigation

Updated Category News Views 317

Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 7

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 172

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 215

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
OREF Opens $185,000 Research Grant Funding Cycle Today

Updated Category News Views 66

A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...

Continue Reading
Armada Moves up as Key Player in US SI Exports

Updated Category News Views 207

Pioneering New Grounds in Intelligence Infrastructure Hell of a move by Armada, stepping into the limelight as a priority team leader in the U.S. SI Exports Program. The whole gig is under the Department of Commerce's belt, pushing the frontier of America's Super Intelligence (SI) technology to buddies across the globe. It's like watching the next big blockbuster unfold...

Continue Reading
Intel Faces Class Action Over Alleged Securities Fraud

Updated Category News Views 122

Intel's Legal Predicament: Decoding the Lawsuit Saddle up, folks, because Intel (NASDAQ: INTC) has found itself tangled in legal vines again. This ain't their first rodeo, and probably won't be their last. We're looking at a hefty class action lawsuit rallying on claims that Intel misled investors with optimistic yarns about their health. SBS Law, waving the litigation...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 26

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading

Top 5 Most Recently Viewed Articles

T-Mobile US: A Decade of Impressive Stock Growth Revealed

Updated Category News Views 142

T-Mobile US and Its Remarkable Growth Journey T-Mobile US (NASDAQ: TMUS) has shown exceptional growth over the last decade. With an annualized return rate of 20.05%, the company has outpaced the broader market by 8.22%. As of the latest information available, T-Mobile's market capitalization stands at an impressive $269.40 billion, highlighting its substantial position...

Continue Reading
Analysts Adjust TFI International's Forecasts After Q3 Report

Updated Category News Views 67

TFI International Reports Weaker-Than-Expected Q3 Earnings After the market closed on a recent Monday, TFI International (NYSE: TFII) announced its quarterly earnings figures, which unfortunately fell below expectations. The company reported earnings of $1.60 per share, compared to analyst predictions of $1.78 per share. In addition, TFI International's quarterly revenue...

Continue Reading
C3.ai Investors Face Class Action Amidst Poor Financial Results

Updated Category News Views 179

C3.ai Class Action Overview The Portnoy Law Firm is stepping forward to represent investors of C3.ai, Inc. as a class action develops. This legal move comes after concerning preliminary financial results announced by the company. Investors who purchased securities of C3 during the specified class period are encouraged to engage with the firm. Details of the Legal Class...

Continue Reading
21st.BIO Seeks EU Nod for Precision Fermentation Tech

Updated Category News Views 172

Is Precision Fermentation Europe's Next Big Bet? Here we go again with another tech trying to revolutionize the food industry, and this time it's the Danish company 21st.BIO making strides in Europe. They've tossed their hat in the ring with an EU Novel Food application for BLG Essential+™, hoping to weave precision fermentation into the fabric of European food...

Continue Reading
Key Pfizer Executives Support Current Leadership Amid Challenges

Updated Category News Views 105

Support for Pfizer's Leadership from Former Executives In a recent statement, former Pfizer executives, Ian Read and Frank D'Amelio, clarified their stance regarding the ongoing campaign by activist investor Starboard Value. They emphasized that they will not be engaging with Starboard, which has been advocating for changes within the pharmaceutical giant to enhance its...

Continue Reading